Aastrom Biosciences, Inc. Reports Third Quarter Fiscal Year 2004 Financial Results Ann Arbor, Michigan, April 29, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM), today reported financial results for the third quarter of fiscal year 2004 ended March 31, 2004.

Aastrom Biosciences to Hold Investor Conference Call Tomorrow Ann Arbor, Michigan, April 28, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today that it will hold an investor conference call tomorrow, Thursday, April 29, 2004 at 11:00 a.m. (EDT).

Aastrom Biosciences to Hold Investor Conference Call Ann Arbor, Michigan, April 27, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) today announced that it will hold an investor conference call on Thursday, April 29, 2004 at 11:00 a.m. (EDT). The purpose of the call will be to bring shareholders

-- Aastrom's Proprietary Technology Used to Produce Therapeutic Quantities of T-Cells --

Aastrom Biosciences Corrects Warrant Exercise Price Related to April 5, 2004 Sale of Common Stock Ann Arbor, Michigan, April 6, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today that the exercise price of the warrants issued to a group of institutional investors was $1.65 per share

Aastrom Biosciences Announces $9.1 Million Private Placement of Common Stock Ann Arbor, Michigan, April 5, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today that it has placed 8 million shares of common stock with institutional investors at approximately $1.14 per share, for an

-- Aastrom's Proprietary TRCs to be Utilized in Second European Clinical Study to Treat Major Bone Fractures --

-- New Form Simplifies Enrollment for Shareholders with Shares in "Street Name" --

-- Patent Covers Bone Marrow, Blood and Cord Blood-Sourced Products --

Aastrom Biosciences' CEO to Present at Roth Capital Partners 16th Annual Growth Stock Conference Ann Arbor, Michigan, February 12, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today that R. Douglas Armstrong, Ph.D., Chairman, President and Chief Executive Officer, has been invited